InBioGen Co Ltd (101140) — Cash Flow Reinvestment Rate

Latest as of December 2024: 0.09x

InBioGen Co Ltd (101140) has a Cash Flow Reinvestment Rate of 0.09x as of December 2024, reinvesting ₩117.75 Million (capex ₩60.00 Million plus investments ₩-57.75 Million) from operating cash flow of ₩1.36 Billion. Explore 101140 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.09x

(Capex + Investments) / Operating CF

Total Reinvested

₩117.75 Million

Capex + Investments

Operating Cash Flow

₩1.36 Billion

KRW

Capital Expenditures

₩60.00 Million

KRW

InBioGen Co Ltd Cash Flow Reinvestment Rate (2016–2016)

Historical reinvestment intensity for InBioGen Co Ltd across 1 annual periods. Also explore 101140 asset base for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for InBioGen Co Ltd (2016–2016)

Year-by-year capital reinvestment analysis for InBioGen Co Ltd. For live market cap and broader valuation context, see InBioGen Co Ltd (101140) total market value.

Year	Reinvestment Rate	Total Reinvested (KRW)	Operating CF	Capex	YoY Change
2016	0.03x	₩8.98 Million	₩344.75 Million	₩0.00	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow